Frequency of the metabolic syndrome in screened South African corporate executives

Cardiovascular Journal of South Africa

Volumn 18, Issue 1, 2007, Pages 30-33

  Ker, J A ^a   Rheeder, P ^a   Van Tonder, R ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FITNESS; HUMAN; MAJOR CLINICAL STUDY; MALE; MANAGER; MEDICAL SPECIALIST; METABOLIC SYNDROME X; MORBIDITY; PREVALENCE; SCORING SYSTEM; SCREENING TEST; SOUTH AFRICA; WAIST CIRCUMFERENCE; HEALTH CARE;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERTENSION; MALE; MASS SCREENING; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PREVALENCE; RESEARCH DESIGN; SOUTH AFRICA; TRIGLYCERIDES; WAIST-HIP RATIO;

EID: 34247463756     PISSN: 10159657     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Kylin E. Studien ueber das hypertonie-hyperglykämie- hyperurikämie syndrom. Zentralblatt Fuer Innere Med 1923; 44: 105-127.
2. Himsworth HP. Diabetes mellitus - its differentiation into insulin sensitive and insulin insensitive types. Lancet 1936; 1: 127-130.
3. Reaven GM. Bunting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
4. Kaplan NM. The deadly quartet: upper-body obesity, glucose intolerance, hypertriglyceridemia and hypertension. Arch Intern Med 1989; 149: 1514-1520.
5. Alberti K, Zimmet P. Definition, diagnosis and classification of diabetes mellitus and its complications. Diabet Med 1998; 15: 539-553.
6. Grundy SM, Cleeman JL, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: a statement for health care professionals: an American Heart Association/National Heart, Lung and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-2752.
7. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabet Care 2001; 24: 683-689.
8. Ford ES, Giles WJ, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. J Am Med Assoc 2002; 287: 356-359.
9. Grep L, Forsblom C, et al. Metabolic consequences of a family history of NIDDM (the Bornia study). Diabetes 1996; 45: 1585-1593.
10. Grundy SM, Hansen B, Smith SC, et al. Clinical management of metabolic syndrome. Circulation 2004; 109: 551-556.
11. Huddle KRL, Kalk WJ, eds. Practical Diabetes Management, 3rd edn. Johannesburg: Wits Diabetes Group, 1994.
12. Alberti KGMM, Zimmet P, Shaw J, the IDF Epidemiology Task Force consensus group. Metabolic syndrome: a new worldwide definition. Lancer 2005; 366: 1059-1062.
13. McLoughlin T, Abbasi F, Cheal K, et al. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med 2003; 139: 802-809.
14. Gundy SM. Does the metabolic syndrome exist? Diabet Care 2006; 29: 1689-1692.
15. Rantala AO, Kauma H, et al. Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects. J Intern Med 1999; 245: 163-174.
16. Kahn R. The metabolic syndrome (emperor) wears no clothes. Diabet Care 2006; 29: 1693-1696.
17. Després JP, Lemieux I, Prud'homme D. Treatment of obesity: need to focus on high-risk abdominally obese patients. Br Med J 2001; 322: 716-722.
18. Reilly MP, Rader DJ. The metabolic syndrome. More than the sum of its parts? Circulation 2003; 108: 1546-1551.